# A Clinical Study to Evaluate the Sensitizing Potential of LEO 43204 Gel

> **NCT02650505** · PHASE1 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 233 (actual)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** LEO 43204
- **DRUG:** LEO 43204 Vehicle

## Key facts

- **NCT ID:** NCT02650505
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 233 (ACTUAL)
- **Last updated:** 2025-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02650505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02650505, "A Clinical Study to Evaluate the Sensitizing Potential of LEO 43204 Gel". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02650505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*